Literature DB >> 11440988

OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance.

U E Pesch1, B Leo-Kottler, S Mayer, B Jurklies, U Kellner, E Apfelstedt-Sylla, E Zrenner, C Alexander, B Wissinger.   

Abstract

We and others have shown recently that mutations in the OPA1 gene encoding a dynamin-related mitochondrial protein cause autosomal dominant optic atrophy (ADOA) linked to chromosome 3q28-q29. Here we report screening of the OPA1 gene in a sample of 78 independent ADOA families. OPA1 mutations were identified in 25 patients (detection rate 32.1%) including 16 novel mutations. We successfully amplified OPA1 cDNA prepared from leukocyte RNA of three patients, and found the amount of transcripts harboring the Arg366Stop mutation was significantly reduced compared with transcripts derived from the normal chromosome. Analysis of the distribution of OPA1 mutations in ADOA revealed that most missense mutations cluster within the putative GTPase domain, and that there is a preponderance of mutations, which result in premature translation termination. These observations support the notion that haploinsufficiency may represent a major pathomechanism for ADOA. In addition, we identified an ADOA patient who is a compound heterozygote for two OPA1 missense mutations. The fact that this patient is by far more severely affected than her simple heterozygotic parents and siblings implies that at least these OPA1 alleles behave semi-dominantly rather than purely dominantly. Clinical examination revealed considerable variability in disease expression among patients carrying OPA1 mutations and no strict correlation with either the position or the type of mutation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440988     DOI: 10.1093/hmg/10.13.1359

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  58 in total

1.  OPA1 mutations in Japanese patients suspected to have autosomal dominant optic atrophy.

Authors:  Tetsuya Hamahata; Takuro Fujimaki; Keiko Fujiki; Ai Miyazaki; Atsushi Mizota; Akira Murakami
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

Review 2.  Cell signaling and mitochondrial dynamics: Implications for neuronal function and neurodegenerative disease.

Authors:  Theodore J Wilson; Andrew M Slupe; Stefan Strack
Journal:  Neurobiol Dis       Date:  2012-01-24       Impact factor: 5.996

3.  The OPA1 Gene Mutations Are Frequent in Han Chinese Patients with Suspected Optic Neuropathy.

Authors:  A-Mei Zhang; Rui Bi; Qiu-Xiang Hu; Yu Fan; Qingjiong Zhang; Yong-Gang Yao
Journal:  Mol Neurobiol       Date:  2016-02-11       Impact factor: 5.590

4.  A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy.

Authors:  Elena Cardaioli; Gian Nicola Gallus; Paola Da Pozzo; Alessandra Rufa; Rossella Franceschini; Eduardo Motolese; Aldo Caporossi; Maria T Dotti; Antonio Federico
Journal:  J Neurol       Date:  2005-12-12       Impact factor: 4.849

5.  Activation of cryptic splice sites is a frequent splicing defect mechanism caused by mutations in exon and intron sequences of the OPA1 gene.

Authors:  Simone Schimpf; Simone Schaich; Bernd Wissinger
Journal:  Hum Genet       Date:  2005-12-02       Impact factor: 4.132

6.  A novel mutation of the OPA1 gene in a Japanese patient with autosomal dominant optic atrophy.

Authors:  Yuriko Ban; Yusuke Yoshida; Satoshi Kawasaki; Chikako Mochida
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-06-20       Impact factor: 3.117

7.  Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.

Authors:  M Votruba; D Thiselton; S S Bhattacharya
Journal:  Br J Ophthalmol       Date:  2003-01       Impact factor: 4.638

8.  A phenotypic variation of dominant optic atrophy and deafness (ADOAD) due to a novel OPA1 mutation.

Authors:  Maria Liguori; Antonella La Russa; Ida Manna; Virginia Andreoli; Manuela Caracciolo; Patrizia Spadafora; Rita Cittadella; Aldo Quattrone
Journal:  J Neurol       Date:  2008-01-22       Impact factor: 4.849

9.  Multi-system neurological disease is common in patients with OPA1 mutations.

Authors:  P Yu-Wai-Man; P G Griffiths; G S Gorman; C M Lourenco; A F Wright; M Auer-Grumbach; A Toscano; O Musumeci; M L Valentino; L Caporali; C Lamperti; C M Tallaksen; P Duffey; J Miller; R G Whittaker; M R Baker; M J Jackson; M P Clarke; B Dhillon; B Czermin; J D Stewart; G Hudson; P Reynier; D Bonneau; W Marques; G Lenaers; R McFarland; R W Taylor; D M Turnbull; M Votruba; M Zeviani; V Carelli; L A Bindoff; R Horvath; P Amati-Bonneau; P F Chinnery
Journal:  Brain       Date:  2010-02-15       Impact factor: 13.501

10.  Identification of two novel OPA1 mutations in Chinese families with autosomal dominant optic atrophy.

Authors:  Yang Li; Ting Deng; Yi Tong; Shuling Peng; Bing Dong; Dacheng He
Journal:  Mol Vis       Date:  2008-12-29       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.